Both in Blank Checks
Bain Capital GSS Investment vs Drugs Made In America Acquisition II
Over the past year BCSS returned +1.4% and DMII returned +3.3%; their daily moves had a correlation of 0.10.
BCSS +1.4% DMII +3.3%Growth of $1, one year, split-adjusted
| Metric | BCSS | DMII |
|---|---|---|
| Price | $10.22 | $10.21 |
| Market cap | $596.8M | $650.4M |
| Today | +0.05% | 0.00% |
| 1 month | −0.5% | +0.2% |
| 6 months | +0.7% | +2.0% |
| Year to date | +1.4% | +3.1% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 4.0% | 1.4% |
| Short % of float | 0.0% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).